← Back to Patent Explorer
US4839279A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for the quantitative determination of physiological components in biological fluids

Assignee: Amano Enzyme Inc
•
Filing: 1985-06-27
•
Granted: 1989-06-13
•
Expires: 2005-06-27
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A novel enzyme of bilirubin oxidase and a conventional enzyme of laccase are found to oxidize bilirubin to biliverdin without formation of hydrogen peroxide, thereby permitting the content of conjugated bilirubin in biological fluid to be quantitatively determined by reacting therewith the bilirubin oxidase of a microorganism of genus Myrothecium origin, and also permitting the content of total bilirubin in biological fluid to be quantitatively determined by reacting therewith such a bilirubin oxidase or laccase in the presence of a specific additive compound.

Inventors

  • 👤 Akira Kosaka
  • 👤 Sawao Murao
  • 👤 Kenichi Hirano
  • 👤 Noriaki Tanaka
  • 👤 Kuniyoshi Matsunaga

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 14:23
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/62; C12Q1/26; C12Q1/54; C12Q1/60; Y; Y10; Y10S; Y10S436/00; Y10S436/811; Y10S436/815; Y10S436/825; Y10T; Y10T436/00; Y10T436/10; Y10T436/103332; Y10T436/14; Y10T436/142222; Y10T436/143333; Y10T436/144444; Y10T436/145555; Y10T436/146666; Y10T436/25; Y10T436/25125

Claims Analysis

Total Claims: 18
Claim 1
Independent Claim 124 words
A method for differential determination of bilirubin in biological fluids, comprising the steps of: allowing bilirubin oxidase produced by a microorganism of the genus Myrothecium to act on an aliquot of a biological fluid to determine conjugated bilirubin in the biological fluid, allowing an enzyme selected from the group consisting of bilirubin oxidase and laccase, together with at least one reaction accelerator selected from the group consisting of surface active agents, aromatic carboxylic acids, sulfa drugs and proteases to act on another aliquot of said biological fluid for a sufficient amount of time to react with both conjugated and unconjugated bilirubins without the formation of hydrogen peroxide to determine the total bilirubin in the biological fluid, whereby conjugated and unconjugated bilirubins are determined differentially.
Claim 2
Independent Claim 124 words
A method for differential determination of bilirubin in biological fluids, comprising the steps of: allowing bilirubin oxidase produced by a microorganism of the genus Myrothecium to act on an aliquot of a biological fluid to determine conjugated bilirubin in the biological fluid, allowing an enzyme selected from the group consisting of bilirubin oxidase and laccase, together with at least one reaction accelerator selected from the group consisting of surface active agents, aromatic carboxylic acids, sulfa drugs and proteases to act on another aliquot of said biological fluid for a sufficient amount of time to react with both conjugated and unconjugated bilirubins without the formation of hydrogen peroxide to determine the total bilirubin in the biological fluid, whereby conjugated and unconjugated bilirubins are determined differentially.
Claim 3
Dependent Claim 29 words
A method according to claim 1, wherein said enzyme is bilirubin oxidase and is selected from the group consisting of Myrothecium sp. bilirubin oxidase and Coprinus sp. bilirubin oxidase.
Claim 4
Dependent Claim 23 words
Method of claim 1 wherein said enzyme is laccase and is selected from the group consisting of lacquer plant laccase and basidiomycete laccase.
Claim 5
Dependent Claim 85 words
Method of claim 1 wherein said enzyme is said bilirubin oxidase and said bilirubin oxidase is present in an amount sufficient for providing a concentration thereof in the corresponding reaction mixture equal to 0.003 to 0.40 U/ml, or said enzyme is laccase and said laccase is present in an amount sufficient for providing a concentration thereof in the corresponding reaction mixture equal to 0.06 to 7.0 mU/ml, one unit being the amount of the corresponding said enzyme which oxidizes one micromole of bilirubin per minute.
Claim 6
Dependent Claim 34 words
Method of claim 1 wherein said additive agent is at least one additive agent selected from the group consisting of sodium cholate, taurocholic acid, sodium dodecyl sulfate, p-toluenesulfonic acid, salicylic acid and sulfosalicylic acid.
Claim 7
Dependent Claim 34 words
Method of claim 5 wherein said additive agent is sodium dodecyl sulfate and is present in an amount sufficient for providing a concentration of 0.5 to 10 mM thereof in the corresponding reaction mixture.
Claim 8
Dependent Claim 33 words
Method of claim 5 wherein said additive agent is sodium cholate and is present in an amount sufficient for providing a concentration of 2 to 30 mM thereof in the corresponding reaction mixture.
Claim 9
Dependent Claim 14 words
Method of claim 1, wherein said treating is carried out at an alkaline pH.
Claim 10
Dependent Claim 96 words
In the method for the quantitative determination of an unknown concentration of total bilirubin in biological fluids, the improvement which comprises treating a biological fluid having an unknown concentration of bilirubin therein without the formation of hydrogen peroxide, under conditions and for a sufficient amount of time to react both the conjugated bilirubin content thereof and the unconjugated content thereof with an enzyme selected from the group consisting of bilirubin oxidase and laccase, together with at least one additive agent selected from the group consisting of surface active agents, aromatic carboxylic acids, sulfa drugs, and proteases.
Claim 11
Dependent Claim 96 words
In the method for the quantitative determination of an unknown concentration of total bilirubin in biological fluids, the improvement which comprises treating a biological fluid having an unknown concentration of bilirubin therein without the formation of hydrogen peroxide, under conditions and for a sufficient amount of time to react both the conjugated bilirubin content thereof and the unconjugated content thereof with an enzyme selected from the group consisting of bilirubin oxidase and laccase, together with at least one additive agent selected from the group consisting of surface active agents, aromatic carboxylic acids, sulfa drugs, and proteases.
Claim 12
Dependent Claim 27 words
Method of claim 9, wherein said enzyme is bilirubin oxidase and is selected from the group consisting of Myrothecium sp. bilirubin oxidase and Coprinus sp. bilirubin oxidase.
Claim 13
Dependent Claim 23 words
Method of claim 9 wherein said enzyme is laccase and is selected from the group consisting of lacquer plant laccase and basidiomycete laccase.
Claim 14
Dependent Claim 87 words
Method of claim 9 wherein said enzyme is said bilirubin oxidase and said bilirubin oxidase is present in an amount sufficient for providing a concentration thereof in the corresponding reaction mixture equal to 0.003 to 0.40 U/ml, or said enzyme is said laccase and said laccase is present in an amount sufficient for providing a concentration thereof in the corresponding reaction mixture equal to 0.06 to 7.0 m U/ml, one unit being the amount of the corresponding said enzyme which oxidizes one micromole of bilirubin per minute.
Claim 15
Dependent Claim 34 words
Method of claim 9 wherein said additive agent is at least one additive agent selected from the group consisting of sodium cholate, taurocholic acid, sodium dodecyl sulfate, p-toluenesulfonic acid, salicylic acid and sulfosalicylic acid.
Claim 16
Dependent Claim 34 words
Method of claim 13 wherein said additive agent is sodium dodecyl sulfate and is present in an amount sufficient for providing a concentration of 0.5 to 10 mM thereof in the corresponding reaction mixture.
Claim 17
Dependent Claim 33 words
Method of claim 13 wherein said additive agent is sodium cholate and is present in an amount sufficient for providing a concentration of 2 to 30 mM thereof in the corresponding reaction mixture.
Claim 18
Dependent Claim 14 words
Method of claim 9 wherein said treating is carried out at an alkaline pH.

References Cited (Backward Citations)

US4211844A Cited
US4571383A Cited
US4701411A Cited
US4600689A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-06-12 1992-12-12 1993-06-13 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-06-12 1996-12-12 1997-06-13 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-06-12 2000-12-12 2001-06-13 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag